anticoagulation

DEFINITION of anticoagulation

Anticoagulation refers to the therapeutic or physiological process of preventing or inhibiting blood coagulation — the cascade of clotting factor activations that converts fibrinogen to fibrin and solidifies a clot. Clinically, anticoagulation is achieved through drug classes that target different points of the coagulation cascade: heparins (UFH, LMWH) potentiate antithrombin III; warfarin (Coumadin) inhibits vitamin K-dependent factors (II, VII, IX, X); and direct oral anticoagulants (DOACs) — including rivaroxaban (Xarelto), apixaban (Eliquis), dabigatran (Pradaxa), and edoxaban — directly inhibit either Factor Xa or thrombin (Factor IIa). Common indications include atrial fibrillation, DVT/PE treatment and prophylaxis, mechanical heart valves, and antiphospholipid antibody syndrome (APS). Anticoagulation differs critically from antiplatelet therapy (e.g., aspirin, clopidogrel), which targets platelet aggregation — a distinction with direct CPT and ICD-10 coding implications.

---

ETYMOLOGY of anticoagulation

greek latin

Component	Origin	Meaning
anti-	Greek ἀντί (antí)	“Against,” “opposed to,” “preventive”
coagul-	Latin coagulare	”To cause to curdle,” “to clot,” “to congeal”
-at-	Latin past participle stem -atus/-ata	Indicates completed action — “having been curdled”
-ion	Latin -io/-ionem	Noun-forming suffix — “act or process of”

The root coagulare derives from cogere — a compound of com- (“together”) + agere (“to drive”) — literally “to drive together.” The earliest use of coagulant (noun) dates to 1770, from Latin coagulantem. The adjective anticoagulant appeared in 1886, with the noun following by 1896. Note the hybrid construction: Greek anti- joined to a Latin root, a pairing common in 19th-century medical neologisms. The related word coagulum referred to rennet used to curdle milk — the same biological “driving together” of proteins that underlies clot formation in blood.

---

🔀 ALIASES / ALTERNATE TERMS

• Anticoagulant (the drug agent itself; e.g., “anticoagulant therapy”)
• Blood thinner (lay term — a misnomer, as blood viscosity is not truly reduced)
• Antithrombotic therapy (broader term encompassing both anticoagulants and antiplatelets)
• AC therapy (common clinical abbreviation)
• Warfarin therapy / Coumadin therapy (when specifically vitamin K antagonist-based)
• DOAC therapy / NOAC therapy (Direct/Novel Oral Anticoagulant)
• Heparin therapy (unfractionated heparin — UFH — or LMWH-specific)
• INR management (warfarin monitoring context)
• Anticoagulation management (clinical service/program context; also a CPT category)
• Therapeutic anticoagulation (dose-level distinction from prophylactic dosing)
• Prophylactic anticoagulation (sub-therapeutic dosing to prevent — not treat — clots)

---

🔗 RELATED TERMS

• Coagulation cascade — the sequential activation of clotting factors (intrinsic, extrinsic, common pathways) that anticoagulants interrupt
• INR (International Normalized Ratio) — standardized PT ratio used to monitor warfarin; therapeutic range typically 2.0-3.0 (or 2.5-3.5 for mechanical valves)
• PT (Prothrombin Time) — monitors extrinsic pathway; used to guide warfarin dosing
• PTT / aPTT (Partial Thromboplastin Time) — monitors intrinsic pathway; used to monitor UFH (heparin) infusions
• Anti-Xa level — used to monitor LMWH (enoxaparin) and some DOACs
• DVT (Deep Vein Thrombosis) — primary indication for anticoagulation
• PE (Pulmonary Embolism) — acute and chronic anticoagulation indication
• Atrial Fibrillation (A-fib) — anticoagulation used to prevent cardioembolic stroke
• Antiphospholipid Antibody Syndrome (APS) — hypercoagulable state; often requires lifelong anticoagulation
• Coagulopathy — disordered clotting; may be a complication of over-anticoagulation
• Hemorrhage / Bleeding complication — chief risk of anticoagulation; drives reversal agent use
• Reversal agents — protamine (heparin reversal), vitamin K / 4-factor PCC (warfarin), andexanet alfa (Factor Xa inhibitor reversal), idarucizumab (dabigatran reversal)
• Thrombocytopenia — platelet-based counterpart; HIT (heparin-induced thrombocytopenia) is a critical anticoagulation complication
• prophylaxis — anticoagulation is one of the most common forms of pharmacological prophylaxis

---

CODING CORNER

🏥 ICD-10-CM CODES

Long-Term Anticoagulant Use (Secondary/Status Code)

Code	Description
Z79.01	Long-term (current) use of anticoagulants (POA Exempt — additive code; never principal Dx)
Z79.02	Long-term (current) use of antithrombotics/antiplatelets

Adverse Effect of Anticoagulants (T45.515 — 7th character required)

Code	Description
T45.515A	Adverse effect of anticoagulants, initial encounter
T45.515D	Adverse effect of anticoagulants, subsequent encounter
T45.515S	Adverse effect of anticoagulants, sequela

Poisoning by Anticoagulants (T45.51x — 7th character required)

Code	Description
T45.511A	Poisoning by anticoagulants, accidental (unintentional), initial encounter
T45.511D	Poisoning by anticoagulants, accidental, subsequent encounter
T45.511S	Poisoning by anticoagulants, accidental, sequela
T45.512A	Poisoning by anticoagulants, intentional self-harm, initial encounter
T45.513A	Poisoning by anticoagulants, assault, initial encounter
T45.514A	Poisoning by anticoagulants, undetermined, initial encounter
T45.516A	Underdosing of anticoagulants, initial encounter
T45.516D	Underdosing of anticoagulants, subsequent encounter
T45.516S	Underdosing of anticoagulants, sequela

Common Conditions Requiring Anticoagulation

Code	Description
I48.0	Paroxysmal atrial fibrillation
I48.11	Longstanding persistent atrial fibrillation
I48.19	Other persistent atrial fibrillation
I48.20	Chronic atrial fibrillation, unspecified
I26.09	Other pulmonary embolism without acute cor pulmonale
I26.99	Other pulmonary embolism without acute cor pulmonale (chronic)
I82.401	Acute embolism and thrombosis of unspecified deep veins of right lower extremity
I82.402	Acute embolism and thrombosis of unspecified deep veins of left lower extremity
D68.61	Antiphospholipid antibody syndrome
Z95.2	Presence of prosthetic heart valve (typically requires lifelong anticoagulation)

Coagulopathy / Abnormal Coagulation

Code	Description
D68.9	Coagulation defect, unspecified
R79.1	Abnormal coagulation profile (supratherapeutic INR without adverse effect)

---

🔧 COMMON CPT CODES (Anticoagulation-Related)

CPT Code	Description
93792	Patient/caregiver training in anticoagulation management for home INR monitoring
93793	Anticoagulant management for a patient taking warfarin; includes review/interpretation of INR, patient instructions, dosage adjustment (as needed), and scheduling of additional test(s)
85610	Prothrombin time (PT)
85730	Thromboplastin time, partial (PTT/aPTT); plasma or whole blood
85732	Thromboplastin time, partial; substitution, plasma fractions, each
85300	Clotting inhibitors or anticoagulants; antithrombin III, activity
85301	Clotting inhibitors or anticoagulants; antithrombin III, antigen
85520	Heparin assay
96365	IV infusion, therapy/prophylaxis/diagnostic; initial substance, up to 1 hour (heparin infusion)
96366	IV infusion, therapy/prophylaxis/diagnostic; each additional hour

---

⚠️ Coding Note: Z79.01 is never a principal diagnosis — it is always additive, coded alongside the condition requiring the anticoagulation (e.g., A-fib, DVT, mechanical valve). On inpatient profee claims, it is a high-yield query target: if the medication rec shows warfarin, heparin, enoxaparin, or a DOAC with no Z79.01 documented, query the provider. For T45.515X, the drug is correctly prescribed and taken but causes an adverse reaction (e.g., supratherapeutic INR with bleeding) — sequence the nature of the adverse effect first (e.g., hemorrhage), then T45.515A. Contrast with T45.511X (poisoning = wrong dose, wrong drug, wrong patient, or intentional overdose). 93793 (warfarin INR management) replaced the retired 99363/99364 codes as of 2018 and cannot be billed the same day as a telehealth E/M. Note that 93793 covers warfarin only — there is no equivalent CPT for DOAC management, which is typically bundled into the E/M.

---

DERIVATIONS of anticoagulation

TABLE definition AS Definition
FROM #medterm 
WHERE length(filter(roots, (word) => econtains([[]].roots, word))) > 0 AND file.name != [[]].file.name
SORT file.name ASC

---

Query functionality

TABLE definition AS Definition
FROM #medterm 
WHERE length(filter(definition, (word) => econtains([[]].definition, word))) > 0 AND file.name != [[]].file.name

Med roots Appendix A Prefixes Appendix B Combining Forms Appendix C Suffixes Appendix D Suffix forms